Über das Projekt
The innovative teledermatology platform Scarletred® Vision runs mobile via App on Smartphones. The system integrates the use of a small patch to standardize the imaging procedure and exchanges anonymised medical data in real time between users and a neuronal machine learning network. The product is supplied global via SaaS to biopharma and cosmetics companies, hospitals, physicians and patients.
Opportunity is when a game changing digital technology like Scarletred® enables delivering more efficient and safer medical treatments and health services faster at lower cost for everyone.
SCARLETRED is a Vienna based international digital health company revolutionising the global dermatology and telemedicine market. Our first product is the multi award winning Scarletred® Vision software platform, a CE certified mobile medical device empowered by a proprietary artificial intelligence core. It is the first technology in the world which enables objective skin imaging and remote skin analysis in more than 3000 cutaneous disorders. With start of the coronavirus pandemics in 2020 Scarletred gained a big momentum in vaccination industry who quickly adopted the new technology for safety monitoring of Covid-19 injections. The company roled out also the novel eCOVID19 telemedicine platform to elderly care homes and drug stores for home based health monitoring. SCARLETRED is honored with the Austria State Prize Digital Solution.